*Correspondence: Baptist Gallwitz [email protected] This article was submitted to Molecular and Structural Endocrinology, a section of the journal Frontiers in Endocrinology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
hence, extreme dieting is not productive in the long run
According to the ADA 2018 Guidelines [1], treatment for T2DM should start with monotherapy unless A1c is greater or equal than 9.0%, when dual therapy must be considered
TGR5 and FXR are expressed in enteroendocrine L-cells in the intestine
Combined, they create an optimal healing milieu where tissue repair, inflammation resolution, gut healing, cell growth, and immune regulation can all occur at once